1. Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs
    Jadd Shelton et al, 2016, Chemical Reviews CrossRef
  2. Two Cases of Long-Term Control of Metastatic Colorectal Cancer via FTD/TPI plus Bevacizumab in Elderly Patients
    Masatsune Shibutani et al, 2018, Case Reports in Oncology CrossRef
  3. TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer
    Cheng-Jiang Liu et al, 2021, Gastroenterology Research and Practice CrossRef
  4. Targeting thymidine phosphorylase alleviates resistance to dendritic cell immunotherapy in colorectal cancer and promotes antitumor immunity
    Ankush Paladhi et al, 2022, Frontiers in Immunology CrossRef
  5. Redefining Later-Line Therapy in Metastatic Colorectal Cancer
    Karen Yee, 2017, European Medical Journal CrossRef
  6. Comparison of the efficacy and safety of third-line treatments for metastatic colorectal cancer: a systematic review and network meta-analysis
    Loulu Gao et al, 2023, Frontiers in Oncology CrossRef
  7. Further Therapeutic Options in Heavily Pretreated Colorectal Cancer Patients
    Aneta L. Zygulska, 2019, Multidisciplinary Approach for Colorectal Cancer CrossRef
  8. Anticancer effects of PEP06 (TB01) in combination with Trifluridine/Tipiracil (TAS-102) in a xenograft model of human colorectal cancer
    Ruohong Lin et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef